Cargando…
Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HAC...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472177/ https://www.ncbi.nlm.nih.gov/pubmed/26088202 http://dx.doi.org/10.1186/s12896-015-0142-z |
_version_ | 1782377015509254144 |
---|---|
author | Hiratsuka, Masaharu Ueda, Kana Uno, Narumi Uno, Katsuhiro Fukuhara, Sayaka Kurosaki, Hajime Takehara, Shoko Osaki, Mitsuhiko Kazuki, Yasuhiro Kurosawa, Yoshikazu Nakamura, Takafumi Katoh, Motonobu Oshimura, Mitsuo |
author_facet | Hiratsuka, Masaharu Ueda, Kana Uno, Narumi Uno, Katsuhiro Fukuhara, Sayaka Kurosaki, Hajime Takehara, Shoko Osaki, Mitsuhiko Kazuki, Yasuhiro Kurosawa, Yoshikazu Nakamura, Takafumi Katoh, Motonobu Oshimura, Mitsuo |
author_sort | Hiratsuka, Masaharu |
collection | PubMed |
description | BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HACs are expected to be promising vectors for modifications of a variety of cell types. However, the method of introduction of HACs into target cells is confined to microcell-mediated chromosome transfer (MMCT), which is less efficient than other methods of vector introduction. Application of Measles Virus (MV) fusogenic proteins to MMCT instead of polyethylene glycol (PEG) has partly solved this drawback, whereas the tropism of MV fusogenic proteins is restricted to human CD46- or SLAM-positive cells. RESULTS: Here, we show that retargeting of microcell fusion by adding anti-Transferrin receptor (TfR) single chain antibodies (scFvs) to the extracellular C-terminus of the MV-H protein improves the efficiency of MV-MMCT to human fibroblasts which originally barely express both native MV receptors, and are therefore resistant to MV-MMCT. Efficacy of chimeric fusogenic proteins was evaluated by the evidence that the HAC, tagged with a drug-resistant gene and an EGFP gene, was transferred from CHO donor cells into human fibroblasts. Furthermore, it was demonstrated that no perturbation of either the HAC status or the functions of transgenes was observed on account of retargeted MV-MMCT when another HAC carrying four reprogramming factors (iHAC) was transferred into human fibroblasts. CONCLUSIONS: Retargeted MV-MMCT using chimeric H protein with scFvs succeeded in extending the cell spectrum for gene transfer via HAC vectors. Therefore, this technology could facilitate the systematic cell engineering by HACs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0142-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4472177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44721772015-06-19 Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome Hiratsuka, Masaharu Ueda, Kana Uno, Narumi Uno, Katsuhiro Fukuhara, Sayaka Kurosaki, Hajime Takehara, Shoko Osaki, Mitsuhiko Kazuki, Yasuhiro Kurosawa, Yoshikazu Nakamura, Takafumi Katoh, Motonobu Oshimura, Mitsuo BMC Biotechnol Methodology Article BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HACs are expected to be promising vectors for modifications of a variety of cell types. However, the method of introduction of HACs into target cells is confined to microcell-mediated chromosome transfer (MMCT), which is less efficient than other methods of vector introduction. Application of Measles Virus (MV) fusogenic proteins to MMCT instead of polyethylene glycol (PEG) has partly solved this drawback, whereas the tropism of MV fusogenic proteins is restricted to human CD46- or SLAM-positive cells. RESULTS: Here, we show that retargeting of microcell fusion by adding anti-Transferrin receptor (TfR) single chain antibodies (scFvs) to the extracellular C-terminus of the MV-H protein improves the efficiency of MV-MMCT to human fibroblasts which originally barely express both native MV receptors, and are therefore resistant to MV-MMCT. Efficacy of chimeric fusogenic proteins was evaluated by the evidence that the HAC, tagged with a drug-resistant gene and an EGFP gene, was transferred from CHO donor cells into human fibroblasts. Furthermore, it was demonstrated that no perturbation of either the HAC status or the functions of transgenes was observed on account of retargeted MV-MMCT when another HAC carrying four reprogramming factors (iHAC) was transferred into human fibroblasts. CONCLUSIONS: Retargeted MV-MMCT using chimeric H protein with scFvs succeeded in extending the cell spectrum for gene transfer via HAC vectors. Therefore, this technology could facilitate the systematic cell engineering by HACs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0142-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-19 /pmc/articles/PMC4472177/ /pubmed/26088202 http://dx.doi.org/10.1186/s12896-015-0142-z Text en © Hiratsuka et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Hiratsuka, Masaharu Ueda, Kana Uno, Narumi Uno, Katsuhiro Fukuhara, Sayaka Kurosaki, Hajime Takehara, Shoko Osaki, Mitsuhiko Kazuki, Yasuhiro Kurosawa, Yoshikazu Nakamura, Takafumi Katoh, Motonobu Oshimura, Mitsuo Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title | Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title_full | Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title_fullStr | Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title_full_unstemmed | Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title_short | Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
title_sort | retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472177/ https://www.ncbi.nlm.nih.gov/pubmed/26088202 http://dx.doi.org/10.1186/s12896-015-0142-z |
work_keys_str_mv | AT hiratsukamasaharu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT uedakana retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT unonarumi retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT unokatsuhiro retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT fukuharasayaka retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT kurosakihajime retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT takeharashoko retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT osakimitsuhiko retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT kazukiyasuhiro retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT kurosawayoshikazu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT nakamuratakafumi retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT katohmotonobu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome AT oshimuramitsuo retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome |